<DOC>
	<DOCNO>NCT00006327</DOCNO>
	<brief_summary>The purpose study determine vaccine , AIDSVAX B/E , protect intravenous drug user become infected HIV .</brief_summary>
	<brief_title>Effectiveness AIDSVAX B/E Vaccine Intravenous Drug Users Bangkok , Thailand</brief_title>
	<detailed_description>Volunteers immunize follow minimum 2 year . Any volunteer becomes infect HIV-1 follow every 4 month post infection 36 month . Behavior effect associate study participation assess .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Volunteers may eligible study : Are 20 60 year old . Are HIVnegative . Have use intravenous drug previous 12 month . Are available commit 3 year followup . Have Thai National ID equivalent government official ID state enterprise ID . Are able understand study pas test showing understand , give write informed consent . Exclusion Criteria Volunteers eligible study : Have serious disease condition , history serious disease condition lymphoma , would interfere study . Are HIVpositive . Have ever receive experimental HIV1 vaccine . Have expect treatment medication interfere immune system ( e.g. , longterm use systemic steroid , chemotherapy , radiation ) . Have receive vaccine immunoglobulin within 2 week receive first study injection , vaccine within 4 week first study injection . Have receive immunoglobulin long time . Have receive nonlicensed , research agent within 4 week first study injection . Expect miss study visit plan move within 36 month . Are pregnant breastfeeding plan become pregnant 36month study period . Are woman sex men plan use effective birth control .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>Recombinant Proteins</keyword>
	<keyword>HIV-1</keyword>
	<keyword>AIDS Serodiagnosis</keyword>
	<keyword>Substance Abuse , Intravenous</keyword>
	<keyword>Enzyme-Linked Immunosorbent Assay</keyword>
	<keyword>Blotting , Western</keyword>
	<keyword>HIV Envelope Protein gp120</keyword>
	<keyword>AIDSVAX</keyword>
</DOC>